Cargando…

Nexus between PI3K/AKT and Estrogen Receptor Signaling in Breast Cancer

SIMPLE SUMMARY: Breast cancers are broadly classified into two subtypes: estrogen receptor-positive and estrogen receptor-negative. Approximately 70% of breast cancers are estrogen receptor-positive and this type of breast cancer is more common in postmenopausal women. Estrogen receptor-positive bre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khatpe, Aditi S., Adebayo, Adedeji K., Herodotou, Christopher A., Kumar, Brijesh, Nakshatri, Harikrishna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864210/ https://www.ncbi.nlm.nih.gov/pubmed/33498407 http://dx.doi.org/10.3390/cancers13030369

Ejemplares similares

Interplay between estrogen receptor and AKT in Estradiol-induced alternative splicing
por: Bhat-Nakshatri, Poornima, et al.
Publicado: (2013)

Stromal heterogeneity may explain increased incidence of metaplastic breast cancer in women of African descent
por: Kumar, Brijesh, et al.
Publicado: (2023)

The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer
por: Golden, Emily, et al.
Publicado: (2021)

Estrogen Receptor Signaling and the PI3K/Akt Pathway Are Involved in Betulinic Acid-Induced eNOS Activation
por: Hohmann, Nicolas, et al.
Publicado: (2016)

AKT1 Transcriptomic Landscape in Breast Cancer Cells
por: George, Bijesh, et al.
Publicado: (2022)

Radiation resistance in breast cancer: are CD44(+)/CD24(-)/proteosome(low)/PKH26(+ )cells to blame?
por: Nakshatri, Harikrishna
Publicado: (2010)

Estrogen Receptor and PI3K/Akt Signaling Pathway Involvement in S-(-)Equol-Induced Activation of Nrf2/ARE in Endothelial Cells
por: Zhang, Ting, et al.
Publicado: (2013)

Ethnicity-Dependent and -Independent Heterogeneity in Healthy Normal Breast Hierarchy Impacts Tumor Characterization
por: Nakshatri, Harikrishna, et al.
Publicado: (2015)

Systemic Actions of Breast Cancer Facilitate Functional Limitations
por: Wang, Ruizhong, et al.
Publicado: (2020)

Targeting the PI3K/Akt/mTOR pathway in estrogen-receptor positive HER2 negative advanced breast cancer
por: du Rusquec, Pauline, et al.
Publicado: (2020)

Chromatin regulation at the intersection of estrogen receptor and PI3K pathways in breast cancer
por: Castel, Pau, et al.
Publicado: (2019)

Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression
por: Bowers, Laura W, et al.
Publicado: (2013)

Estrogen receptor alpha drives mTORC1 inhibitor-induced feedback activation of PI3K/AKT in ER+ breast cancer
por: Yang, Wei, et al.
Publicado: (2018)

Elevated estrogen receptor β expression in triple negative breast cancer cells is associated with sensitivity to doxorubicin by inhibiting the PI3K/AKT/mTOR signaling pathway
por: Lei, Shanshan, et al.
Publicado: (2020)

Telomeres and Estrogens: The Unholy Nexus in Pathogenesis of Atherosclerosis
por: Sameer, Aga Syed, et al.
Publicado: (2014)

Spatholobus suberectus Column Extract Inhibits Estrogen Receptor Positive Breast Cancer via Suppressing ER MAPK PI3K/AKT Pathway
por: Sun, Jia-Qi, et al.
Publicado: (2016)

Nontranscriptional activation of PI3K/Akt signaling mediates hypotensive effect following activation of estrogen receptor β in the rostral ventrolateral medulla of rats
por: Wu, Kay LH, et al.
Publicado: (2012)

Astragali Radix Isoflavones Synergistically Alleviate Cerebral Ischemia and Reperfusion Injury Via Activating Estrogen Receptor-PI3K-Akt Signaling Pathway
por: Gu, Yong, et al.
Publicado: (2021)

Estrogen downregulates CD73/adenosine axis hyperactivity via adaptive modulation PI3K/Akt signaling to prevent myocarditis and arrhythmias during chronic catecholamines stress
por: Ndzie Noah, Marie Louise, et al.
Publicado: (2023)

CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells
por: Nguyen Hoang, Anh Thu, et al.
Publicado: (2021)

Tumor collection/processing under physioxia uncovers highly relevant signaling networks and drug sensitivity
por: Kumar, Brijesh, et al.
Publicado: (2022)

Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells
por: Burnett, Riesa M., et al.
Publicado: (2015)

Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
por: Li, Huayi, et al.
Publicado: (2021)

Retraction: Astragali radix isoflavones synergistically alleviate cerebral ischemia and reperfusion injury via activating estrogen receptor-PI3K-Akt signaling pathway
Publicado: (2023)

Estrogen receptor β exhibited anti-tumor effects on osteosarcoma cells by regulating integrin, IAP, NF-kB/BCL-2 and PI3K/Akt signal pathway
por: Yang, Minfei, et al.
Publicado: (2017)

Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity
por: Bhat-Nakshatri, Poornima, et al.
Publicado: (2013)

Acquisition, processing, and single-cell analysis of normal human breast tissues from a biobank
por: Bhat-Nakshatri, Poornima, et al.
Publicado: (2021)

The effects of Ginsenosides on PI3K/AKT signaling pathway
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

Biomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitors
por: Brandão, M, et al.
Publicado: (2019)

PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement
por: Bonin, S., et al.
Publicado: (2019)

Estrogen Receptor Signaling in Breast Cancer
por: Miziak, Paulina, et al.
Publicado: (2023)

Inhibition of PI3K/AKT molecular pathway mediated by membrane estrogen receptor GPER accounts for cryptotanshinone induced antiproliferative effect on breast cancer SKBR-3 cells
por: Shi, Danning, et al.
Publicado: (2020)

G Protein-Coupled Estrogen Receptor 1 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy via the Regulation of PI3K-Akt-mTOR Signalling and Autophagy
por: Pei, Hui, et al.
Publicado: (2019)

SLUG/SNAI2 and Tumor Necrosis Factor Generate Breast Cells With CD44+/CD24- Phenotype
por: Bhat-Nakshatri, Poornima, et al.
Publicado: (2010)

Involvement of PI3K/Akt/β-catenin signaling in schisandrin B-mitigated bone deterioration in an experimental rat model of estrogen deficiency
por: Liang, Yimin, et al.
Publicado: (2020)

The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization
por: Tóthová, Zuzana, et al.
Publicado: (2021)

K-ras/PI3K-Akt Signaling Is Essential for Zebrafish Hematopoiesis and Angiogenesis
por: Liu, Lihui, et al.
Publicado: (2008)

Signal Transduction Pathways in Breast Cancer: The Important Role of PI3K/Akt/mTOR
por: Ortega, Miguel A., et al.
Publicado: (2020)

circ_103809 promotes breast cancer progression by regulating the PI3K/AKT signaling pathway
por: Qiu, Xiaoli, et al.
Publicado: (2020)

KAT7 promotes radioresistance through upregulating PI3K/AKT signaling in breast cancer
por: Ma, Yan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6iqnprucr60vm4ip45d30ug4hl